These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3065723)

  • 41. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4.
    Donsmark M; Herold L; Kristensen CM
    Diabetes Technol Ther; 2009 Sep; 11(9):581-5. PubMed ID: 19764837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Intensive insulin therapy in adolescents with type 1 diabetes mellitus: initial experiences with a semiautomatic insulin injection device (the insulin pen)].
    Schönle EJ
    Schweiz Med Wochenschr; 1987 Nov; 117(45):1756-60. PubMed ID: 3321425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals.
    Olsen BS; Lilleøre SK; Korsholm CN; Kracht T
    J Diabetes Sci Technol; 2010 Nov; 4(6):1468-75. PubMed ID: 21129343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients.
    Bak JF; Nielsen OH; Pedersen O; Beck-Nielsen H
    Diabetes Res; 1987 Nov; 6(3):155-8. PubMed ID: 3325220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S; Vaag A; Langkjaer L; Hougaard P; Markussen J
    BMJ; 1989 Aug; 299(6696):415-9. PubMed ID: 2506998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical experience with a new device that will simplify insulin injections.
    Berger AS; Saurbrey N; Kühl C; Villumsen J
    Diabetes Care; 1985; 8(1):73-6. PubMed ID: 3882371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the practical use of the Becton-Dickinson (B-D) insulin pen injector].
    Sieradzki J; Koblik T
    Przegl Lek; 1994; 51(12):510-2. PubMed ID: 7746886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multi-injection treatment using an insulin pen].
    Foss NE; Gustavsen I; Støa K
    Tidsskr Nor Laegeforen; 1990 Mar; 110(7):833-4. PubMed ID: 2181729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.
    Dunbar JM; Madden PM; Gleeson DT; Fiad TM; McKenna TJ
    Diabetes Care; 1994 Aug; 17(8):874-8. PubMed ID: 7956634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies.
    Friedrichs A; Basso N; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved diabetic control in adolescents using the Penject syringe for multiple insulin injections.
    McCaughey ES; Betts PR; Rowe DJ
    Diabet Med; 1986 May; 3(3):234-6. PubMed ID: 2951175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes--the REMIND study.
    Adolfsson P; Veijola R; Huot C; Hansen HD; Lademann JB; Phillip M
    Curr Med Res Opin; 2012 Sep; 28(9):1455-63. PubMed ID: 22640459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of intensified insulin regimen on quality of life and metabolic control in insulin-dependent diabetes mellitus.
    Karlson B; Agardh CD
    Diabetes Res Clin Pract; 1994 Sep; 25(2):111-5. PubMed ID: 7821190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [1 years' experience with Novopen and Insuject--a survey of 50 insulin-dependent diabetic patients].
    Ganz K
    Schweiz Rundsch Med Prax; 1988 Sep; 77(38):1013-4. PubMed ID: 3051264
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.
    Graff MR; McClanahan MA
    Clin Ther; 1998; 20(3):486-96. PubMed ID: 9663364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experiences with functional insulin substitution: a follow-up study on control and patient compliance.
    Fövényi J; Szövérffy G; Thaisz E; Lehotkai L; Wettstein A
    Acta Med Hung; 1992-1993; 49(1-2):53-64. PubMed ID: 1296187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.